ResearcherHenan Provincial People's HospitalNo recent work listed

Yaping Zhai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2403-7310; OpenAlex author ID A5057178319. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. Last author DOI 10.1080/21655979.2021.2023800 ↗
Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma. Co-author DOI 10.2147/ott.s279287 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yasi Xing · 1 shared paper, 2022 · strength 0.17
- Paper The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. DOI 10.1080/21655979.2021.2023800 ↗
Yuanxiang Lu · 1 shared paper, 2021 · strength 0.12
- Paper Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.2147/ott.s279287 ↗
Yujin Pan · 1 shared paper, 2021 · strength 0.12
- Paper Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.2147/ott.s279287 ↗
Guoyi Yan · 1 shared paper, 2021 · strength 0.12
- Paper Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma. DOI 10.2147/ott.s279287 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.